Literature DB >> 12618754

Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.

Michimoto Kobayashi1, Akihiro Iwamatsu, Azusa Shinohara-Kanda, Sayoko Ihara, Yasuhisa Fukui.   

Abstract

Signet-ring cell carcinomas are malignant dedifferentiated carcinomas, which are frequently found in the stomach. We previously demonstrated that a 200 kDa protein is often constitutively phosphorylated on tyrosine and bound to phosphatidylinositol 3-kinase (PI3-kinase) in signet-ring cell carcinoma cells. In this study, we purified the 200 kDa protein from an extract of NUGC-4 cells, a cell line of signet-ring cell carcinoma, and identified it as ErbB3. ErbB3 was found to be phosphorylated selectively in dedifferentiated adenocarcinoma cell lines among various gastric cancer cell lines. Expression of a constitutively active chimeric receptor consisting of ErbB2 and ErbB3 in HCC2998 cells, a highly differentiated adenocarcinoma cell line, revealed that the signaling triggered by phosphorylation of ErbB3 was important for dedifferentiated phenotypes such as loss of cell-cell interaction and high expression of MUC1/DF3 antigen, a marker of the malignant tumors. Taken together, activation of ErbB3 pathway may contribute to the development of dedifferentiated carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618754     DOI: 10.1038/sj.onc.1206256

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

2.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 3.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

Review 4.  The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.

Authors:  Masakazu Yashiro; Tasuku Matsuoka; Masaichi Ohira
Journal:  Hum Cell       Date:  2018-06-06       Impact factor: 4.174

Review 5.  Clinical management of advanced gastric cancer: the role of new molecular drugs.

Authors:  Ferdinando De Vita; Natale Di Martino; Alessio Fabozzi; Maria Maddalena Laterza; Jole Ventriglia; Beatrice Savastano; Angelica Petrillo; Valentina Gambardella; Vincenzo Sforza; Luigi Marano; Annamaria Auricchio; Gennaro Galizia; Fortunato Ciardiello; Michele Orditura
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.

Authors:  Daekee Lee; Ming Yu; Eunjung Lee; Hyunok Kim; Yanan Yang; Kyoungmi Kim; Christina Pannicia; Jonathan M Kurie; David W Threadgill
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

7.  Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.

Authors:  Xiu Li Zhang; Yun Sheng Yang; Dong Ping Xu; Jian Hui Qu; Ming Zhou Guo; Yan Gong; Jin Huang
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

Review 8.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

Review 9.  Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.

Authors:  Neha Sami; Vijay Kumar; Asimul Islam; Sher Ali; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

10.  Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants.

Authors:  Kathy Yuen Yee Chan; Fiona Wan Lun Leung; Hugh Simon Lam; Yuk Him Tam; Ka Fai To; Hon Ming Cheung; Kam Tong Leung; Terence Chuen Wai Poon; Kim Hung Lee; Karen Li; Tai Fai Fok; Pak Cheung Ng
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.